{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T01:37:44Z","timestamp":1790386664838,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100008966","name":"Soci\u00e9t\u00e9 Francophone du Diab\u00e8te","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008966","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006258","name":"Comisi\u00f3n de Investigaciones Cient\u00edficas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006258","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.jdiacomp.2017.04.024","type":"journal-article","created":{"date-parts":[[2017,5,11]],"date-time":"2017-05-11T08:48:32Z","timestamp":1494492512000},"page":"1103-1108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Urinary lysophopholipids are increased in diabetic patients with nephropathy"],"prefix":"10.1016","volume":"31","author":[{"given":"Jean-S\u00e9bastien","family":"Saulnier-Blache","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Feigerlova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Michel","family":"Halimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Gourdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronan","family":"Roussel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Guerci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aude","family":"Dupuy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine","family":"Bertrand-Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Loup","family":"Bascands","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samy","family":"Hadjadj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost P.","family":"Schanstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdiacomp.2017.04.024_bb0005","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejphar.2016.08.022","article-title":"Mechanistic insight of diabetic nephropathy and its pharmacotherapeutic targets: an update","volume":"791","author":"Bhattacharjee","year":"2016","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jdiacomp.2017.04.024_bb0010","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.dsx.2015.02.008","article-title":"Management of diabetic nephropathy: recent progress and future perspective","volume":"9","author":"Ahmad","year":"2015","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.jdiacomp.2017.04.024_bb0015","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1038\/sj.ki.5001834","article-title":"Lipotoxicity","volume":"70","author":"Weinberg","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.jdiacomp.2017.04.024_bb0020","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s11892-015-0611-8","article-title":"The evolving understanding of the contribution of lipid metabolism to diabetic kidney disease","volume":"15","author":"Stadler","year":"2015","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.jdiacomp.2017.04.024_bb0025","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/bs.acc.2014.11.002","article-title":"Lipidomics: new insight into kidney disease","volume":"68","author":"Zhao","year":"2015","journal-title":"Adv Clin Chem"},{"key":"10.1016\/j.jdiacomp.2017.04.024_bb0030","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1111\/j.1523-1755.2005.09916.x","article-title":"Dyslipidemia and the progression of renal disease in chronic renal failure patients","author":"Cases","year":"2005","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.jdiacomp.2017.04.024_bb0035","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1681\/ASN.2016020231","article-title":"The genetic landscape of renal complications in type 1 diabetes","volume":"28","author":"Sandholm","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jdiacomp.2017.04.024_bb0040","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11255-014-0843-6","article-title":"The association between lipid metabolism gene polymorphisms and nephropathy in type 2 diabetes: a meta-analysis","volume":"47","author":"Li","year":"2015","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.jdiacomp.2017.04.024_bb0045","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.jdiacomp.2015.06.016","article-title":"Metabolomic biomarkers in diabetic kidney diseases\u2014a systematic review","volume":"29","author":"Zhang","year":"2015","journal-title":"J Diabetes Complicat"},{"key":"10.1016\/j.jdiacomp.2017.04.024_bb0050","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1046\/j.1523-1755.2001.00487.x","article-title":"Effect of lipid reduction on the progression of renal disease: a meta-analysis","volume":"59","author":"Fried","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.jdiacomp.2017.04.024_bb0055","doi-asserted-by":"crossref","first-page":"3612","DOI":"10.1093\/ndt\/gfl437","article-title":"Lysophospholipase D activity exists in the urine to catalyse the formation of lysophosphatidic acid","volume":"21","author":"Ohkawa","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jdiacomp.2017.04.024_bb0060","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.lfs.2011.06.001","article-title":"Presence of bioactive lysophosphatidic acid in renal effluent of rats with unilateral ureteral obstruction","volume":"89","author":"Tsutsumi","year":"2011","journal-title":"Life Sci"},{"key":"10.1016\/j.jdiacomp.2017.04.024_bb0065","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1042\/bj3450061","article-title":"Characterization of plasma unsaturated lysophosphatidylcholines in human and rat","volume":"345","author":"Croset","year":"2000","journal-title":"Biochem J"},{"key":"10.1016\/j.jdiacomp.2017.04.024_bb0070","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1681\/ASN.2007020196","article-title":"LPA1 receptor activation promotes renal interstitial fibrosis","volume":"18","author":"Pradere","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jdiacomp.2017.04.024_bb0075","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1517\/13543784.2011.566864","article-title":"Lysophosphatidic acid-1-receptor targeting agents for fibrosis","volume":"20","author":"Rancoule","year":"2011","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.jdiacomp.2017.04.024_bb0080","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1210\/endo-120-2-595","article-title":"Stimulation of phosphatidylcholine biosynthesis in diabetic hypertrophic kidneys","volume":"120","author":"Suzuki","year":"1987","journal-title":"Endocrinology"},{"key":"10.1016\/j.jdiacomp.2017.04.024_bb0085","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1194\/jlr.M049189","article-title":"Diabetic nephropathy induces alterations in the glomerular and tubule lipid profiles","volume":"55","author":"Grove","year":"2014","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jdiacomp.2017.04.024_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.kint.2016.11.010","article-title":"Blocking lysophosphatidic acid receptor 1 signaling inhibits diabetic nephropathy in db\/db mice","author":"Li","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.jdiacomp.2017.04.024_bb0095","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.2337\/dc07-2079","volume":"31","author":"Hadjadj","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2017.04.024_bb0100","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s13105-016-0518-0","article-title":"Increased urinary lysophosphatidic acid in mouse with subtotal nephrectomy: potential involvement in chronic kidney disease","volume":"72","author":"Mirzoyan","year":"2016","journal-title":"J Physiol Biochem"},{"key":"10.1016\/j.jdiacomp.2017.04.024_bb0105","doi-asserted-by":"crossref","first-page":"356","DOI":"10.5414\/CNP63356","article-title":"Enhanced expression of group IIA secreted phospholipase A2 by elevated glucose levels in cytokine-stimulated rat mesangial cells and in kidneys of diabetic rats","volume":"63","author":"Vlachojannis","year":"2005","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.jdiacomp.2017.04.024_bb0110","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/1440-1681.12494","article-title":"Increased sphingosine 1-phosphate mediates inflammation and fibrosis in tubular injury in diabetic nephropathy","volume":"43","author":"Yaghobian","year":"2016","journal-title":"Clin Exp Pharmacol Physiol"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872717303057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872717303057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,9]],"date-time":"2022-07-09T03:24:36Z","timestamp":1657337076000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872717303057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S1056872717303057"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2017.04.024","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urinary lysophopholipids are increased in diabetic patients with nephropathy","name":"articletitle","label":"Article Title"},{"value":"Journal of Diabetes and its Complications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2017.04.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}